Lung deposition of nebulized surfactant in newborn piglets: Nasal CPAP vs Nasal IPPV

Nasal continuous positive airway pressure support (nCPAP) is the standard of care for prematurely born infants at risk of neonatal respiratory distress syndrome (nRDS). However, nasal intermittent positive pressure ventilation (NIPPV) may be an alternative to nCPAP in babies requiring surfactant, and in conjunction with surfactant nebulization, it could theoretically reduce the need for invasive mechanical ventilation. We compared lung deposition of nebulized poractant in newborn piglets supported by nCPAP or NIPPV.

[1]  M. Schlun,et al.  From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy , 2019, Respiratory Research.

[2]  G. Greisen,et al.  European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update , 2019, Neonatology.

[3]  J. Pillow,et al.  Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[4]  W. Göpel,et al.  Less invasive surfactant administration and complications of preterm birth , 2018, Scientific Reports.

[5]  A. Berlinski,et al.  Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit , 2018, Respiratory Care.

[6]  A. Kribs.  Minimally Invasive Surfactant Therapy and Noninvasive Respiratory Support. , 2016, Clinics in perinatology.

[7]  M. Kumar,et al.  Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis , 2016, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[8]  A. Jobe.  Mechanisms of Lung Injury and Bronchopulmonary Dysplasia , 2016, American Journal of Perinatology.

[9]  J. Beyene,et al.  Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. , 2016, JAMA.

[10]  C. O. Kamlin,et al.  Incidence and Outcome of CPAP Failure in Preterm Infants , 2016, Pediatrics.

[11]  P. Davis,et al.  Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. , 2016, The Cochrane database of systematic reviews.

[12]  E. Lopriore,et al.  Sedation during Minimal Invasive Surfactant Therapy in Preterm Infants , 2016, Neonatology.

[13]  H. Ozkan,et al.  Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[14]  S. Karahan,et al.  Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial , 2015, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[15]  A. Aliverti,et al.  The effect of exogenous surfactant on alveolar interdependence , 2015, Respiratory Physiology & Neurobiology.

[16]  R. Linner,et al.  Lung Deposition of Nebulized Surfactant in Newborn Piglets , 2015, Neonatology.

[17]  L. Papile,et al.  Respiratory Support in Preterm Infants at Birth , 2014, Pediatrics.

[18]  P. Davis,et al.  Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. , 2014, The Cochrane database of systematic reviews.

[19]  R. V. van Lingen,et al.  Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[20]  L. Mecklenburg,et al.  The non-intubated, spontaneously breathing, continuous positive airway pressure (CPAP) ventilated pre-term lamb: a unique animal model. , 2012, Reproductive toxicology.

[21]  J. Pillow,et al.  Innovation in Surfactant Therapy II: Surfactant Administration by Aerosolization , 2012, Neonatology.

[22]  R. Dhand.  Aerosol therapy in patients receiving noninvasive positive pressure ventilation. , 2012, Journal of aerosol medicine and pulmonary drug delivery.

[23]  P. Dargaville,et al.  Preliminary evaluation of a new technique of minimally invasive surfactant therapy , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[24]  R. Polin,et al.  Aerosol delivery to ventilated newborn infants: historical challenges and new directions , 2010, European Journal of Pediatrics.

[25]  Abhik Das,et al.  Early CPAP versus surfactant in extremely preterm infants. , 2010, The New England journal of medicine.

[26]  A. Jobe.  Mechanisms to Explain Surfactant Responses , 2006, Neonatology.

[27]  Eliza H. Myers,et al.  Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. , 2007, The Cochrane database of systematic reviews.

[28]  C. Dani,et al.  Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. , 2004, Pediatrics.

[29]  J. Fink.  Aerosol delivery to ventilated infant and pediatric patients. , 2004, Respiratory care.

[30]  M. Blennow,et al.  Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. , 2002, The Cochrane database of systematic reviews.

[31]  Arthur S Slutsky,et al.  Lung injury in neonates: causes, strategies for prevention, and long-term consequences. , 2001, The Journal of pediatrics.

[32]  T. Schaible,et al.  To the editor: Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants , 1997, Pediatric pulmonology.

[33]  J. A. Schipper,et al.  The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function , 1997, European Journal of Pediatrics.

[34]  G. Enhorning,et al.  Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. , 1972, Pediatrics.